Rybelsus 7 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FE2H3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,739
Award facts
- Contract value 100% obligated
- $10,738.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,738.94 to AmerisourceBergen Drug Corp for the supply of Rybelsus 7 mg tablets in quantities of 30 units. This firm fixed-price contract, awarded on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a non-competitive, non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Rybelsus is an oral semaglutide medication indicated for diabetes management, reflecting the DLA's ongoing pharmaceutical supply needs for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), a $999.99 billion comprehensive pharmaceutical prime vendor agreement running through December 2026. As one of the primary pharmaceutical distributors supporting federal medical procurement, AmerisourceBergen maintains a broad portfolio of brand-name and generic medications, vaccines, and specialized medical supplies serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities globally. The company's contract vehicle supports the military healthcare supply chain with flexible ordering capabilities across multiple therapeutic domains, enabling efficient fulfillment of episodic pharmaceutical requirements such as this tablet delivery.
Quick answers
Who was awarded contract SPE2DB25FE2H3?
SPE2DB25FE2H3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 22, 2025.
How much is contract SPE2DB25FE2H3 worth?
The government has obligated $10,739 on SPE2DB25FE2H3.
Is contract SPE2DB25FE2H3 an order under another contract?
Yes. SPE2DB25FE2H3 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FE2H3 competed?
The extent of competition for SPE2DB25FE2H3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award